CHAMGAP
APPROVEDReviewed and approved by the Chamgap Editorial Team (2026-07-16). The draft was written by AI, the existence of all 3 cited sources was verified at the original page, and the verdict passed blind grading and adversarial audit. Methodology v0.6.
Verdict No. 373 · Search date 2026-07-16 · Methodology v0.6

Paraxanthine,
does it really help with Cleaner alertness, endurance, and reaction speed than caffeine?

30-Second Summary
C
Evidence Grade C · 42 · Safety unknown
Metabolite description, cognitive signals, endurance performance, and long-term safety were separated
What the
research shows
Small crossover trials of enfinity® at 50-200 mg improved selected cognition, memory, and reaction-time measures. Samples were only 12-13 participants, signals appeared in selected outcomes among many tests, and the studies, authors, and funding were connected to the branded-ingredient developer. Caffeine comparisons and long-term safety remain limited, so the grade is C.
What the
ads claim
Phrases such as 'the good caffeine metabolite,' 'no jitters,' and 'no crash' turn metabolic description and small side-effect questionnaires into broad superiority claims.
*

Useful facts when choosing a product

  • Overseas enfinity® products provide 100 or 200 mg per serving; trials used 50-200 mg.
  • In Korea, availability is centered on imported or overseas-purchase energy products rather than a broadly recognized standalone functional-health product.
  • The supplier suggests 100-200 mg, but a long-term clinical dose has not been established.
  • Human efficacy trials are acute to seven days, leaving long-term cardiovascular, sleep, and tolerance safety unknown.
Gap Measurement · Verdict 373 · C 42
What advertising claims
What independent, higher-quality research supports
△ GAP
01

What the research actually shows

Yoo 2021 reported selected card-sorting, Sternberg, and vigilance improvements with 200 mg in 13 participants. Xing 2021 tested 50, 100, and 200 mg in 12 participants and reported more consistent signals at 100-200 mg. Yoo 2024 compared placebo, caffeine, paraxanthine, and their combination in 12 trained runners and found selected post-10-km executive and reaction-time signals, but did not establish superior endurance performance.

02

Why this is classified as C (42)

Repeated small-sample signals exist, but acute 12-13-person enfinity® trials, manufacturer support, multiple cognitive outcomes, limited caffeine comparison, and absent long-term data yield C with 42 points. Being a caffeine metabolite does not prove a cleaner or superior effect.

Counterpoint. A sufficiently powered independent caffeine-comparator trial should prespecify primary outcomes and assess real endurance, jitters, sleep, and tolerance.

Rejudgment record. Reassessment (cross-check reflected) — Accepted signals from acute 12-13-person enfinity trials but rejected transfer from metabolite status to superiority and retained C for branded and manufacturer concentration

Sub-claim grades by effect

This ingredient is marketed for several effects. A single overall grade blends strong and weak claims together, so each effect is graded separately here. The overall grade reflects the strongest disconfirming or core claim.

Effect (sub-claim)GradeBasis
Alertness, cognition, and reaction speedCSelected positive outcomes in 12-13-person branded-ingredient crossover trials
Cleaner than caffeineCOnly a 12-person comparison and short-term side-effect questionnaires
Improved endurance performance?The 10-km trial mainly assessed post-exercise cognition; direct endurance superiority evidence was not identified

Cross-check — Codex and Claude

This verdict was drafted by Codex through literature review and source-existence checks, cross-checked through blind grading and adversarial audit, and settled by reapplying the methodology boundary rules. Cases with split grades were resolved through rejudgment.
03

Evidence Table

StudyDesignSampleFundingEndpointResultWeight
Yoo et al. (2021)Randomized double-blind placebo-controlled crossover trial13Funded by Ingenious Ingredients with affiliated authorsMemory, executive function, vigilance, and reaction timeSelected outcomes improved with 200 mgKey
Xing et al. (2021)Randomized dose-response crossover trial12Ingenious Ingredients funding and branded ingredientCognition, memory, reaction time, and safetySignals were more consistent at 100-200 mg across 50-200 mgSupportive
Yoo et al. (2024)Double-blind four-condition crossover trial12Ingenious Ingredients funding and affiliated authorsExecutive function, vigilance, and reaction time after a 10-km runSelected post-exercise cognitive signals versus placebo or caffeineSupportive
§

Receipt — 3 References

All 3 cited sources were verified for existence at the original page (as of 2026-07-16).

Yoo C, Xing D, Gonzalez D, et al. Acute Paraxanthine Ingestion Improves Cognition and Short-Term Memory and Helps Sustain Attention in a Double-Blind, Placebo-Controlled, Crossover Trial. Nutrients. 2021;13(11):3980. PMID: 34836235. DOI: 10.3390/nu13113980.
checked
Xing D, Yoo C, Gonzalez D, et al. Dose-Response of Paraxanthine on Cognitive Function: A Double Blind, Placebo Controlled, Crossover Trial. Nutrients. 2021;13(12):4478. PMID: 34960030. DOI: 10.3390/nu13124478.
checked
Yoo C, Xing D, Gonzalez DE, et al. Paraxanthine provides greater improvement in cognitive function than caffeine after performing a 10-km run. J Int Soc Sports Nutr. 2024;21(1):2352779. PMID: 38725238. DOI: 10.1080/15502783.2024.2352779.
checked
Draft and rewrite: Codex (AI) · Verification: Codex blind grading and adversarial audit · Final adjudication: Claude
Reviewed and approved: Chamgap Editorial Team · Approval date: 2026-07-16 · Corrections: none

Cite this verdict

Paraxanthine (enfinity®) x cleaner alertness, endurance, and reaction speed Evidence Grade C card
[Chamgap] Paraxanthine (enfinity®) x cleaner alertness, endurance, and reaction speed — Evidence Grade C·42. 3 cited sources checked. Source: https://chamgap.com/en/verdicts/energy/paraxanthine-enfinity-alertness-endurance-reaction-time/ · CC BY 4.0

CC BY 4.0 — free to use with attribution; do not distort grades, numbers, or verdict meaning.

!

What this document does and does not do

Chamgap is an information source. It reports what research has and has not confirmed; it does not tell readers what to take or buy. That decision belongs to readers and, when needed, medical or legal professionals. This verdict reflects literature available up to the search date and may change as new research appears. Nothing here is medical advice.